Karuna Therapeutics
Boston
About Karuna Therapeutics
Karuna Therapeutics is a biopharmaceutical company that develops treatments for psychiatric and neurological conditions. Karuna Therapeutics creates drugs that can significantly improve the lives of people who suffer from neurological and psychiatric illnesses, with a particular focus on schizophrenia and the behavioral symptoms of Alzheimer's disease. The company is skilled in neuroscience and has creative ideas for finding and developing new drugs. Karuna Therapeutics is advancing a pipeline of innovative drugs since its inception with the aim of significantly improving the lives of people suffering from these difficult conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $1.6B
- Funding stage: M&A
- Last round: Post-IPO Equity (Mar 2023)
- Ticker: nasdaq:KRTX
- Website: karunatx.com
- Phone: 6174823337
Industries & Categories
Biopharma, Health Care, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/karuna-therapeutics-4134 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.